BioAscent

BioAscent is a Scotland-based integrated drug discovery contract research organisation providing science-led services to biotech, pharmaceutical, and academic customers.

Operating from the former MSD R&D site in Newhouse, its capabilities span assay development, high-throughput screening, medicinal and synthetic chemistry, computational chemistry, DMPK, and compound management.

The company manages over 1.5 million compounds on behalf of clients and maintains in-house diversity and fragment libraries for hit-finding programmes.